BLOOD CELLS MOLECULES AND DISEASES

Scope & Guideline

Connecting Molecular Biology to Hematologic Health

Introduction

Welcome to your portal for understanding BLOOD CELLS MOLECULES AND DISEASES, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1079-9796
PublisherACADEMIC PRESS INC ELSEVIER SCIENCE
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1995 to 2025
AbbreviationBLOOD CELL MOL DIS / Blood Cells Mol. Dis.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address525 B ST, STE 1900, SAN DIEGO, CA 92101-4495

Aims and Scopes

The journal 'Blood Cells, Molecules and Diseases' primarily focuses on the cellular and molecular aspects of hematology and the pathophysiology of blood-related disorders. It aims to provide a platform for the dissemination of research findings that enhance our understanding of blood cells and their associated diseases, utilizing a variety of methodologies.
  1. Hematopoietic Stem Cell Research:
    This area encompasses studies focusing on hematopoietic stem cells, their differentiation, and their role in various hematological disorders, including aplastic anemia and sickle cell disease.
  2. Genetic and Molecular Characterization of Blood Disorders:
    Research in this scope investigates the genetic mutations and molecular mechanisms underlying various blood disorders such as thalassemia, hemophilia, and leukemias, often employing advanced genomic technologies.
  3. Clinical and Translational Studies:
    The journal publishes clinical studies that evaluate treatment efficacy, disease management strategies, and outcomes in patients with blood diseases, emphasizing the translational aspect of research.
  4. Pathophysiology of Hematological Conditions:
    This includes investigations into the mechanisms of diseases affecting blood cells, such as inflammation, oxidative stress, and immune responses, contributing to a deeper understanding of disease progression.
  5. Innovative Therapeutic Approaches:
    Research on novel therapies, including gene therapy, small molecules, and immunotherapies aimed at treating blood disorders, is a key focus, highlighting advancements in treatment methodologies.
Recent publications in 'Blood Cells, Molecules and Diseases' have highlighted several trending and emerging themes that reflect the evolving nature of hematological research.
  1. Impact of COVID-19 on Hematological Disorders:
    With the ongoing global pandemic, there has been an increase in research examining how COVID-19 affects patients with existing hematological conditions, highlighting the interplay between infectious diseases and blood disorders.
  2. MicroRNA and Epigenetic Regulation:
    Research focusing on the role of microRNAs and epigenetic modifications in the pathogenesis of blood disorders has gained momentum, indicating a growing interest in molecular regulation mechanisms.
  3. Use of Artificial Intelligence and Machine Learning:
    The application of AI and machine learning in diagnostics and treatment planning for blood disorders is emerging, with studies exploring their potential to improve clinical outcomes.
  4. Personalized Medicine in Hematology:
    There is an increasing emphasis on personalized medicine approaches, utilizing genetic profiling to tailor treatments for individual patients, particularly in conditions like sickle cell disease and thalassemias.
  5. Clinical Trials of Novel Therapeutics:
    A significant trend is the increase in clinical trials testing new therapies, particularly in the context of gene therapy and novel pharmacological agents aimed at improving patient outcomes.

Declining or Waning

Over the years, certain themes within 'Blood Cells, Molecules and Diseases' have shown a decline in prominence, reflecting shifts in research focus or changes in the scientific landscape.
  1. Traditional Hematology Techniques:
    There has been a noticeable decrease in studies employing traditional hematology techniques, such as manual blood smear analysis, as the field shifts towards more advanced, automated, and molecular methodologies.
  2. General Reviews on Hematological Disorders:
    While comprehensive reviews were once common, the trend has shifted towards more focused studies that provide novel insights or specific case studies, leading to fewer general reviews being published.
  3. Epidemiological Studies:
    The frequency of broad epidemiological studies on blood disorders has diminished, possibly due to a focus on more localized or specific population studies that yield more actionable insights.

Similar Journals

CELLULAR & MOLECULAR BIOLOGY LETTERS

Unlocking the Secrets of Life at the Molecular Level
Publisher: BMCISSN: 1425-8153Frequency: 1 issue/year

CELLULAR & MOLECULAR BIOLOGY LETTERS, published by BMC, is a premier open-access journal dedicated to disseminating high-quality research in the fields of Biochemistry, Cell Biology, and Molecular Biology. Established in 1996, the journal has emerged as a leader in its domain, boasting an impressive Q1 ranking across three critical categories as of 2023, reflecting its significant impact within the scientific community. With an ISSN of 1425-8153 and an E-ISSN of 1689-1392, it offers accessible research findings to a global audience, having been open access since 2013. Situated in the United Kingdom, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, the journal continues to serve as a vital resource for researchers, professionals, and students, contributing to advancements in the understanding of cellular and molecular processes. By providing a platform for original research, reviews, and short communications, CELLULAR & MOLECULAR BIOLOGY LETTERS plays a crucial role in fostering dialogue and collaboration within the scientific community.

Immunological Medicine

Catalyzing Change Through Open Access Research
Publisher: TAYLOR & FRANCIS LTDISSN: Frequency: 4 issues/year

Immunological Medicine, published by Taylor & Francis Ltd, is an esteemed open-access journal that has made significant strides in the field of immunology since its establishment in 2018. With an E-ISSN of 2578-5826, the journal has quickly gained recognition for its contribution to advancing immunological research, evidenced by its impressive ranking in the Q2 quartile for both immunology and allergy. Positioned in the United Kingdom, it offers a platform for publishing high-quality original research, reviews, and case studies that delve into the complex interactions of the immune system and its implications for human health. The journal serves as a vital resource for researchers, professionals, and students engaged in the burgeoning fields of immunology, providing open access to a wide audience and fostering collaboration and innovation. With a current Scopus ranking of #81 out of 233 in Immunology and Allergy and #97 out of 236 in Immunology and Microbiology, the journal aims to enhance the visibility and impact of cutting-edge research by bridging the gap between academia and clinical practice.

STEM CELLS AND DEVELOPMENT

Exploring the Potential of Stem Cells in Science
Publisher: MARY ANN LIEBERT, INCISSN: 1547-3287Frequency: 24 issues/year

STEM CELLS AND DEVELOPMENT, published by Mary Ann Liebert, Inc., is a leading peer-reviewed journal dedicated to the rapidly advancing fields of stem cell biology and developmental science. With an ISSN of 1547-3287 and an E-ISSN of 1557-8534, the journal encompasses a broad range of topics central to understanding stem cells' roles in development and regeneration processes. It holds a prestigious standing within its category quartiles, ranking Q3 in Cell Biology, Q2 in Developmental Biology, and Q2 in Hematology for 2023. With its convergence from 2004 to 2024, STEM CELLS AND DEVELOPMENT fosters an innovative platform for researchers, professionals, and students to disseminate groundbreaking research, share insights, and explore novel therapeutic approaches. Open access options enhance the journal's visibility and accessibility, promoting a collaborative exchange of information among the scientific community. Positioned at the forefront of stem cell research and its applications, this journal is vital for anyone seeking to stay informed about the latest advancements and trends within these critical areas of study.

MOLECULAR NEUROBIOLOGY

Pioneering Discoveries in Molecular Mechanisms of the Brain
Publisher: SPRINGERISSN: 0893-7648Frequency: 12 issues/year

Welcome to Molecular Neurobiology, the premier journal dedicated to the exploration of the molecular mechanisms underlying nervous system function and pathophysiology. Published by Springer, this journal provides an essential platform for disseminating high-quality research in the rapidly evolving fields of Cellular and Molecular Neuroscience and Neurology, boasting an impressive impact factor that reflects its esteemed position within the academic community. With its ranking in the Q1 and Q2 quartiles for various neuroscience categories, Molecular Neurobiology stands at the forefront of groundbreaking discoveries, showcasing innovative studies that bridge basic science and clinical application. Researchers and professionals are invited to contribute to its rich portfolio, which spans from fundamental insights into cellular processes to advanced therapeutic strategies. Although Molecular Neurobiology does not operate as an Open Access journal, its influential body of work remains accessible through institutional and personal subscriptions. As we converge from 1987 to 2024, we continue to aim for excellence, seeking to catalyze progress in understanding neurological diseases and enhance the scientific dialogue within the neuroscience community.

TRANSFUSION MEDICINE AND HEMOTHERAPY

Elevating the standards of hemotherapy and transfusion practices.
Publisher: KARGERISSN: 1660-3796Frequency: 6 issues/year

TRANSFUSION MEDICINE AND HEMOTHERAPY, published by KARGER, is a prominent journal dedicated to advancing the fields of hematology and transfusion medicine. With an ISSN of 1660-3796 and E-ISSN 1660-3818, this esteemed journal has been a valuable resource for researchers and clinicians since its inception in 1973, with significant publication phases continuing into 2024. It currently holds a Q2 ranking in Hematology and a Q3 ranking in Immunology and Allergy, reflecting its impact and relevance in these critical fields. The journal features original articles, reviews, and clinical studies, presenting cutting-edge research that aids in the development of effective therapies and enhances patient care. Open access options are available, ensuring that crucial findings are accessible to a broad audience. As an important platform for dialogue and advancement in transfusion science, TRANSFUSION MEDICINE AND HEMOTHERAPY supports the global health community's efforts to improve treatment outcomes and foster innovation in medical practices.

JOURNAL OF GENE MEDICINE

Exploring the Future of Genetic Innovation
Publisher: WILEYISSN: 1099-498XFrequency: 12 issues/year

The Journal of Gene Medicine, published by Wiley, stands as a pivotal resource in the field of gene therapy and molecular medicine, with a rich history of dissemination of impactful research since its inception in 1998. With an ISSN of 1099-498X and an E-ISSN of 1521-2254, this esteemed journal plays a crucial role in advancing our understanding of genetics and drug discovery, reflected in its impressive 2023 Scopus rankings where it holds a Q2 classification in Drug Discovery and Q3 in several genetics-related categories. The journal aims to facilitate the exchange of high-quality research findings that bridge the gap between laboratory and clinical applications, making it an essential platform for researchers, academics, and healthcare professionals committed to the forefront of genetic innovation. Although it does not currently offer open access options, its reputation for rigorous peer review ensures that all published work meets the highest academic standards, providing a reliable reference for scientific inquiry in the United States and beyond. As the field rapidly evolves, the Journal of Gene Medicine remains at the helm, guiding future discoveries with its influential publications and comprehensive insights.

Inflammation and Regeneration

Advancing the frontiers of immunology and regenerative medicine.
Publisher: BMCISSN: Frequency: 1 issue/year

Inflammation and Regeneration is a prominent open-access journal published by BMC, focused on the discerning fields of immunology, cell biology, and regenerative medicine. Since its establishment in 2016, the journal has provided a platform for the dissemination of high-quality research, contributing significantly to the advancement of knowledge in inflammation processes and regenerative therapies. With a remarkable impact reflected in its Q1 quartile rankings in Cell Biology and Immunology for 2023, Inflammation and Regeneration stands out as a leading resource for researchers and practitioners. The journal's commitment to open access ensures that critical findings are readily available to a global audience, fostering collaboration and innovation in the scientific community. With a Scopus ranking that places it in the top 20% of its categories, Inflammation and Regeneration serves as an essential reference for those seeking to stay at the forefront of immunological research and its applications.

JOURNAL OF INVESTIGATIVE DERMATOLOGY

Illuminating Pathways in Dermatological Inquiry
Publisher: ELSEVIER SCIENCE INCISSN: 0022-202XFrequency: 12 issues/year

JOURNAL OF INVESTIGATIVE DERMATOLOGY, published by Elsevier Science Inc, stands at the forefront of research in the fields of dermatology, biochemistry, cell biology, and molecular biology. With an impressive impact factor reflecting its Q1 ranking in Dermatology and Biochemistry, this journal provides a vital platform for disseminating groundbreaking research and innovative studies that drive forward our understanding of skin biology and disease. The journal has maintained a distinguished presence since its inception in 1945, successfully converging decades of scientific inquiry and expertise. It ranks among the top journals in medicine and dermatology, holding a remarkable 7th place out of 142 in the Scopus Medicine Dermatology category, signaling its influence and relevance in the academic community. Researchers, professionals, and students alike will find valuable insights into cutting-edge investigations and methodologies to advance their own studies in skin health and pathology. While the journal is not an open access publication, access options remain robust for institutions and individuals committed to the advancement of dermatological science.

DNA AND CELL BIOLOGY

Unraveling the Mysteries of DNA and Cell Dynamics
Publisher: MARY ANN LIEBERT, INCISSN: 1044-5498Frequency: 12 issues/year

DNA AND CELL BIOLOGY, published by Mary Ann Liebert, Inc, is a distinguished journal in the realms of cell biology, genetics, and molecular biology, holding a notable position in its Q3 and Q2 quartile rankings across multiple academic categories as of 2023. With an ISSN of 1044-5498 and an E-ISSN of 1557-7430, this journal has been a pivotal platform for the dissemination of cutting-edge research since its inception in 1990, extending its coverage through 2024. Situated in the United States, the journal offers high-quality peer-reviewed articles, exploring significant advancements in biological sciences while fostering interdisciplinary collaborations within the research community. Though it currently does not offer open access, subscribed institutions and individual readers benefit from its rich repository of knowledge. The journal's rigorous standards and impactful content make it an essential resource for researchers, professionals, and students alike, aiming to stay at the forefront of discoveries influencing DNA and cellular dynamics.

Blood Cancer Discovery

Transforming Research into Life-Saving Solutions
Publisher: AMER ASSOC CANCER RESEARCHISSN: 2643-3230Frequency: 6 issues/year

Blood Cancer Discovery is a premier academic journal published by the American Association for Cancer Research, dedicated to advancing the understanding of hematologic malignancies through cutting-edge research in the fields of oncology, biochemistry, and molecular biology. With an impressive impact factor and recognition as a Q1 journal across multiple disciplines, including cancer research and hematology, Blood Cancer Discovery serves as an essential platform for scholars and practitioners alike, facilitating impactful discourse and dissemination of pioneering findings. This open-access journal, established within the vibrant academic landscape of the United States, aims to bridge gaps in research and foster collaborations to ultimately enhance patient outcomes. Its Scopus rankings demonstrate its vital role in the critical advancement of cancer research and therapeutic development. By inviting contributions from a diverse range of disciplines, Blood Cancer Discovery is poised to drive innovation and inspire future advancements in understanding blood cancers.